IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures

Brain, Behavior, and Immunity

Volumn 25, Issue 7, 2011, Pages 1281-1289

  Vezzani, Annamaria ^a   Maroso, Mattia ^a   Balosso, Silvia ^a   Sanchez, Manuel Alavez ^b   Bartfai, Tamas ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Anticonvulsant; DAMPs; Epilepsy; Interleukins; LPS; PAMPs

Indexed keywords

ANTIINFLAMMATORY AGENT; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR;

BRAIN TISSUE; ENCEPHALITIS; EPILEPSY; INFECTION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE EXCITABILITY; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; STRESS;

HUMANS; INFECTION; INFLAMMATION; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; RECEPTORS, INTERLEUKIN-1; SEIZURES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 79955681780     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.03.018     Document Type: Review

References (92)

1. Alheim K., Bartfai T. The interleukin-1 system: receptors, ligands, and ICE in the brain and their involvement in the fever response. Ann. N. Y. Acad. Sci. 1998, 840:51-58.
2. Allan S.M., Tyrrell P.J., Rothwell N.J. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 2005, 5:629-640.
3. Auvin S., Mazarati A., Shin D., Sankar R. Inflammation enhances epileptogenesis in the developing rat brain. Neurobiol. Dis. 2010, 40:303-310.
4. Balosso S., Maroso M., Sanchez-Alavez M., Ravizza T., Frasca A., Bartfai T., Vezzani A. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain 2008, 131:3256-3265.
5. Ban E., Milon G., Prudhomme N., Fillion G., Haour F. Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 1991, 43:21-30.
6. Banks W.A., Kastin A.J., Durham D.A. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res. Bull. 1989, 23:433-437.
7. Bartfai T., Sanchez-Alavez M., Andell-Jonsson S., Schultzberg M., Vezzani A., Danielsson E., Conti B. Interleukin-1 system in CNS stress: seizures, fever, and neurotrauma. Ann. N. Y. Acad. Sci. 2007, 1113:173-177.
8. Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr. Opin. Immunol. 2000, 12:20-26.
9. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004, 430:257-263.
10. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 2007, 81:1-5.
11. Bsibsi M., Ravid R., Gveric D., van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 2002, 61:1013-1021.
12. Carvey P.M., Hendey B., Monahan A.J. The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. J. Neurochem. 2009, 111:291-314.
13. Chakravarty S., Herkenham M. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J. Neurosci. 2005, 25:1788-1796.
14. Choi J., Nordli D.R., Alden T.D., DiPatri A., Laux L., Kelley K., Rosenow J., Schuele S.U., Rajaram V., Koh S. Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J. Neuroinflamm. 2009, 6:38.
15. Coeshott C., Ohnemus C., Pilyavskaya A., Ross S., Wieczorek M., Kroona H., Leimer A.H., Cheronis J. Converting enzyme-independent release of tumor necrosis factor α and IL-1β from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc. Natl. Acad. Sci. USA 1999, 96:6261-6266.
16. Davis C.N., Mann E., Behrens M.M., Gaidarova S., Rebek M., Rebek J., Bartfai T. MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics. Proc. Natl. Acad. Sci. USA 2006, 103:2953-2958.
17. Davis C.N., Tabarean I., Gaidarova S., Behrens M.M., Bartfai T. IL-1beta induces a MyD88-dependent and ceramide-mediated activation of Src in anterior hypothalamic neurons. J. Neurochem. 2006, 98:1379-1389.
18. De Simoni M.G., Perego C., Ravizza T., Moneta D., Conti M., Marchesi F., De Luigi A., Garattini S., Vezzani A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. NeuroSci. 2000, 12:2623-2633.
19. Diem R., Hobom M., Grotsch P., Kramer B., Bahr M. Interleukin-1 beta protects neurons via the interleukin-1 (IL-1) receptor-mediated Akt pathway and by IL-1 receptor-independent decrease of transmembrane currents in vivo. Mol. Cell. Neurosci. 2003, 22:487-500.
20. Dinarello C.A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011, 117:3720-3732.
21. Eklind S., Hagberg H., Wang X., Savman K., Leverin A.L., Hedtjarn M., Mallard C. Effect of lipopolysaccharide on global gene expression in the immature rat brain. Pediatr. Res. 2006, 60:161-168.
22. Eriksson C., Winblad B., Schultzberg M. Kainic acid induced expression of interleukin-1 receptor antagonist mRNA in the rat brain. Brain Res. Mol. Brain Res. 1998, 58:195-208.
23. Fukao T., Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol. 2003, 24:358-363.
24. Galic M.A., Riazi K., Henderson A.K., Tsutsui S., Pittman Q.J. Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol. Dis. 2009, 36:343-351.
25. Gibson F.C., Yumoto H., Takahashi Y., Chou H.H., Genco C.A. Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. J. Dent. Res. 2006, 85:106-121.
26. Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-934.
27. Gupta Y.K., Briyal S., Chaudhary G. Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats. Pharmacol. Biochem. Behav. 2002, 71:245-249.
28. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
29. Henshall D.C., Clark R.S., Adelson P.D., Chen M., Watkins S.C., Simon R.P. Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy. Neurology 2000, 55:250-257.
30. Herman S.T. Epilepsy after brain insult: targeting epileptogenesis. Neurology 2002, 59:S21-S26.
31. Huttunen H.J., Rauvala H. Amphoterin as an extracellular regulatior of cell motility: from discovery to disease. J. Inter. Med. 2004, 255:351-366.
32. Iyer A., Zurolo E., Spliet W.G., van Rijen P.C., Baayen J.C., Gorter J.A., Aronica E. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 2010, 51:1763-1773.
33. Jack C.S., Arbour N., Manusow J., Montgrain V., Blain M., McCrea E., Shapiro A., Antel J.P. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 2005, 175:4320-4330.
34. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20:197-216.
35. Kulkarni S.K., Dhir A. Cyclooxygenase in epilepsy: from perception to application. Drugs Today (Barc) 2009, 45:135-154.
36. Lai A.Y., Swayze R.D., El-Husseini A., Song C. Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons. J. Neuroimmunol. 2006, 175:97-106.
37. Lee M.S., Kim Y.J. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem. 2007, 76:447-480.
38. Leon C.G., Tory R., Jia J., Sivak O., Wasan K.M. Discovery and development of Toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharm. Res. 2008, 25:1751-1761.
39. Mantovani A., Locati M., Vecchi A., Sozzani S., Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 2001, 22:328-336.
40. Maroso, M., Balosso, S., Ravizza, T., Iori, V., Wright, C.I., French, J., Vezzani, A., 2011. ICE/Caspase 1 inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics. [Epub ahead of print].
41. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A.M., Rossetti C., Molteni M., Casalgrandi M., Manfredi A.A., Bianchi M.E., Vezzani A. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 2010, 16:413-419.
42. Matsuo M., Sasaki K., Ichimaru T., Nakazato S., Hamasaki Y. Increased IL-1beta production from dsRNA-stimulated leukocytes in febrile seizures. Pediatr. Neurol. 2006, 35:102-106.
43. Mouihate A., Horn T.F., Pittman Q.J. Oxyresveratrol dampens neuroimmune responses in vivo: a selective effect on TNF-alpha. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R1215-1221.
44. Nguyen M.D., Julien J.P., Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration?. Nat. Rev. Neurosci. 2002, 3:216-227.
45. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007, 7:353-364.
46. Oby E., Janigro D. The blood-brain barrier and epilepsy. Epilepsia 2006, 47:1761-1774.
47. Okun E., Griffioen K., Barak B., Roberts N.J., Castro K., Pita M.A., Cheng A., Mughal M.R., Wan R., Ashery U., Mattson M.P. Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis. Proc. Natl. Acad. Sci. USA 2010, 107:15625-15630.
48. Okun E., Griffioen K.J., Lathia J.D., Tang S.C., Mattson M.P., Arumugam T.V. Toll-like receptors in neurodegeneration. Brain Res. Rev. 2009, 59:278-292.
49. Pedrazzi M., Patrone M., Passalacqua M., Ranzato E., Colamassaro D., Sparatore B., Pontremoli S., Melloni E. Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling. J. Immunol. 2007, 179:8525-8533.
50. Peltier D.C., Simms A., Farmer J.R., Miller D.J. Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling. J. Immunol. 2010, 184:7010-7021.
51. Pitkanen A. Therapeutic approaches to epileptogenesis--hope on the horizon. Epilepsia 2010, 51(Suppl. 3):2-17.
52. Ravizza T., Boer K., Redeker S., Spliet W.G., van Rijen P.C., Troost D., Vezzani A., Aronica E. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol. Dis. 2006, 24:128-143.
53. Ravizza T., Gagliardi B., Noe F., Boer K., Aronica E., Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 2008, 29:142-160.
54. Ravizza T., Lucas S.M., Balosso S., Bernardino L., Ku G., Noe F., Malva J., Randle J.C., Allan S., Vezzani A. Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia 2006, 47:1160-1168.
55. Ravizza T., Vezzani A. Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. Neuroscience 2006, 137:301-308.
56. Riazi K., Galic M.A., Pittman Q.J. Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res. 2010, 89:34-42.
57. Rodgers K.M., Hutchinson M.R., Northcutt A., Maier S.F., Watkins L.R., Barth D.S. The cortical innate immune response increases local neuronal excitability leading to seizures. Brain 2009, 132:2478-2486.
58. Rogawski M.A., Loscher W. The neurobiology of antiepileptic drugs. Nat. Rev. Neurosci. 2004, 5:553-564.
59. Sakatani S., Seto-Ohshima A., Shinohara Y., Yamamoto Y., Yamamoto H., Itohara S., Hirase H. Neural-activity-dependent release of S100B from astrocytes enhances kainate-induced gamma oscillations in vivo. J. Neurosci. 2008, 28:10928-10936.
60. Sanchez-Alavez M., Tabarean I.V., Behrens M.M., Bartfai T. Ceramide mediates the rapid phase of febrile response to IL-1beta. Proc. Natl. Acad. Sci. USA 2006, 103:2904-2908.
61. Schafers M., Sorkin L. Effect of cytokines on neuronal excitability. Neurosci. Lett. 2008, 437:188-193.
62. Schonbeck U., Mach F., Libby P. Generation of biologically active IL-1β by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1β processing. J. Immunol. 1998, 161:3340-3346.
63. Schwartz M., Shechter R. Systemic inflammatory cells fight off neurodegenerative disease. Nat. Rev. Neurol. 2010, 6:405-410.
64. Seifert G., Schilling K., Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev. Neurosci. 2006, 7:194-206.
65. Shlosberg D., Benifla M., Kaufer D., Friedman A. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol. 2010, 6:393-403.
66. Singh G., Prabhakar S., Modi M. Central nervous system infections and epilepsy. Epilepsia 2008, 49(Suppl. 6):1.
67. Spulber S., Bartfai T., Schultzberg M. IL-1/IL-1ra balance in the brain revisited - evidence from transgenic mouse models. Brain Behav. Immun. 2009, 23:573-579.
68. Srinivasan D., Yen J.H., Joseph D.J., Friedman W. Cell type-specific interleukin-1beta signaling in the CNS. J. Neurosci. 2004, 24:6482-6488.
69. Tabarean I.V., Korn H., Bartfai T. Interleukin-1beta induces hyperpolarization and modulates synaptic inhibition in preoptic and anterior hypothalamic neurons. Neuroscience 2006, 141:1685-1695.
70. Tang S.C., Arumugam T.V., Xu X., Cheng A., Mughal M.R., Jo D.G., Lathia J.D., Siler D.A., Chigurupati S., Ouyang X., Magnus T., Camandola S., Mattson M.P. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. USA 2007, 104:13798-13803.
71. Tsan M.F., Gao B. Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 2004, 76:514-519.
72. Turrin N.P., Rivest S. Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy. Neurobiol. Dis. 2004, 16:321-334.
73. van de Veerdonk F.L., Netea M.G., Dinarello C.A., Joosten L.A. Inflammasome activation and IL-1β and IL-18 processing during infection. Trends Immunol. 2011, 32:110-116.
74. Vercammen E., Staal J., Beyaert R. Sensing of viral infection and activation of innate immunity by Toll-like receptor 3. Clin. Microbiol. Rev. 2008, 21:13-25.
75. Vezzani A., Balosso S., Maroso M., Zardoni D., Noe F., Ravizza T. ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. Curr. Opin. Investig. Drugs 2010, 11:43-50.
76. Vezzani A., Balosso S., Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav. Immun. 2008, 22:797-803.
77. Vezzani A., Conti M., De Luigi A., Ravizza T., Moneta D., Marchesi F., De Simoni M.G. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 1999, 19:5054-5065.
78. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat. Rev. Neurol. 2011, 7:31-40.
79. Vezzani A., Moneta D., Conti M., Richichi C., Ravizza T., De Luigi A., De Simoni M.G., Sperk G., Andell-Jonsson S., Lundkvist J., Iverfeldt K., Bartfai T. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acad. Sci. USA 2000, 97:11534-11539.
80. Virgili M., Contestabile A. Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci. Lett. 2000, 281:123-126.
81. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., Binaglia M., Corsini E., Di Luca M., Galli C.L., Marinovich M. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 2003, 23:8692-8700.
82. Viviani B., Gardoni F., Marinovich M. Cytokines and neuronal ion channels in health and disease. Int. Rev. Neurobiol. 2007, 82:247-263.
83. Wang S., Cheng Q., Malik S., Yang J. Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 2000, 292:497-504.
84. Wilkinson M.F., Mathieson W.B., Pittman Q.J. Interleukin-1 beta has excitatory effects on neurons of the bed nucleus of the stria terminalis. Brain Res. 1993, 625:342-346.
85. Wu Z., Xu Q., Zhang L., Kong D., Ma R., Wang L. Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem. Res. 2009, 34:1393-1400.
86. Yoshimoto T., Nakanishi K. Roles of IL-18 in basophils and mast cells. Allergol. Int. 2006, 55:105-113.
87. Youn H.S., Lee J.Y., Fitzgerald K.A., Young H.A., Akira S., Hwang D.H. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J. Immunol. 2005, 175:3339-3346.
88. Zeise M.L., Espinoza J., Morales P., Nalli A. Interleukin-1beta does not increase synaptic inhibition in hippocampal CA3 pyramidal and dentate gyrus granule cells of the rat in vitro. Brain Res. 1997, 768:341-344.
89. Zhang F., Liu J., Shi J.S. Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur. J. Pharmacol. 2010, 636:1-7.
90. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., Brohi K., Itagaki K., Hauser C.J. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.
91. Zhang R., Yamada J., Hayashi Y., Wu Z., Koyama S., Nakanishi H. Inhibition of NMDA-induced outward currents by interleukin-1beta in hippocampal neurons. Biochem. Biophys. Res. Commun. 2008, 372:816-820.
92. Zurolo, E., Iyer, A., Maroso, M., Carbonell, C., Anink, J.J., Ravizza, T., Fluiter, K., Spliet, W.G.M., van Rijen, P.C., Vezzani, A., Aronica, E., 2011. Activation of TLR, RAGE and HMGB1 signaling in malformation of cortical development. Brain [Epub ahead of print].